Literature DB >> 17592790

Course of cognitive symptoms in schizophrenia: a review of the literature.

N Ojeda1, P Sánchez, E Elizagárate, A B Yöller, J Ezcurra, I Ramírez, J Ballesteros.   

Abstract

Longitudinal studies are the only ones capable of responding to the question of whether cognitive deficits present in schizophrenia follow a stable course and establishing its evolutive relationship with other clinical symptoms of the disease. This article reviews a total of 30 studies published in patients with a first psychotic episode or chronic or geriatric patients, with a minimum follow-up period of 1 year. The diversity in criteria and methods used significantly limits the conclusions that can be drawn on this subject. However, the global tendency of the results suggests that significant and measurable cognitive symptoms are present at the onset of the disease and these remain stable in the subsequent period between 2 and 5 years. Their deterioration increases with the course of the disease, especially in hospitalized patients, it not exceeding the deterioration level presented in other degenerative diseases. The authors are aware that unifying research criteria and overcoming the methodological limitations may offer results that change the conclusions herein gathered in the future.

Entities:  

Mesh:

Year:  2007        PMID: 17592790

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  3 in total

1.  Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.

Authors:  David Walling; Stephen R Marder; John Kane; W Wolfgang Fleischhacker; Richard S E Keefe; David A Hosford; Chris Dvergsten; Anthony C Segreti; Jessica S Beaver; Steven M Toler; John E Jett; Geoffrey C Dunbar
Journal:  Schizophr Bull       Date:  2015-06-12       Impact factor: 9.306

2.  A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.

Authors:  Jeffrey A Lieberman; Geoffrey Dunbar; Anthony C Segreti; Ragy R Girgis; Frances Seoane; Jessica S Beaver; Naihua Duan; David A Hosford
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

3.  The Impact of Health Promotion Activities on the Physiological, Psychological, and Social Functions of Inpatients With Chronic Mental Illness.

Authors:  Yu Li Lan; Lieh Yung Ping; Li Wen Su; Chien Chih Chen
Journal:  Psychiatry Investig       Date:  2022-02-25       Impact factor: 2.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.